SB 24-203 CO

0likes☆Favorite🔕SubscribeShare

Became Law

Current law requires the Colorado prescription drug affordability review board (board) to take certain measures in determining whether to conduct an affordability review for an identified prescription drug. The act requires the board, in making such a determination, to consider whether the drug has an approved orphan drug designation for one or more rare diseases and no other indications and, if so, to consider input from consumers and the Colorado rare disease advisory council (council). Current law requires the board, in performing an affordability review, to consider certain information. The act requires the board to consider input from the council. APPROVED by Governor June 6, 2024 EFFECTIVE August 7, 2024(Note: This summary applies to this bill as enacted.)

• Joann Ginal · primary
• Barbara Kirkmeyer Republican · primary
• Anthony Hartsook Republican · primary
• David Ortiz · primary

1. Jun 6, 2024 Governor Signed · executive
2. May 16, 2024 Sent to the Governor · executive
3. May 16, 2024 Signed by the Speaker of the House · lower
4. May 16, 2024 Signed by the President of the Senate · upper
5. May 5, 2024 House Third Reading Passed - No Amendments · lower
6. May 4, 2024 House Second Reading Special Order - Passed - No Amendments · lower
7. May 2, 2024 House Second Reading Laid Over Daily - No Amendments · lower
8. Apr 29, 2024 House Committee on Health & Human Services Refer Unamended to House Committee of the Whole · lower
9. Apr 23, 2024 Introduced In House - Assigned to Health & Human Services · lower
10. Apr 23, 2024 Senate Third Reading Passed - No Amendments · upper
11. Apr 22, 2024 Senate Second Reading Special Order - Passed - No Amendments · upper
12. Apr 18, 2024 Senate Committee on State, Veterans, & Military Affairs Refer Unamended - Consent Calendar to Senate Committee of the Whole · upper
13. Apr 8, 2024 Introduced In Senate - Assigned to State, Veterans, & Military Affairs · upper